| AFAFP | amniotic fluid alpha-fetoprotein |
|---|---|
| AFP | alpha-fetoprotein; anterior faucial pillar; atypical facial pain |
| AGD | agar gel diffusion; agarose diffusion; alpha-ketoglutarate dehydrogenase |
| AHB | alpha-hydroxybutyric acid |
| AHH | alpha-hydrazine analog of histidine; anosmia and hypogonadotropic hypogonadism [syndrome]; arylhydro... |
| fibroid adenoma | <oncology, tumour> A benign solid growth, usually found in the breast. (09 Oct 1997) |
|---|---|
| lactating adenoma | <tumour> An uncommon adenoma of the breast composed of tubuloacinar structures with pronounced secretory changes such as seen in pregnancy and lactation. (05 Mar 2000) |
| follicular adenoma | <tumour> An adenoma of the thyroid with a simple glandular pattern. (05 Mar 2000) |
| Fuchs' adenoma | <tumour> A benign epithelial tumour of the non-pigmented epithelium of the ciliary body, rarely exceeding 1 mm in diameter. (05 Mar 2000) |
| Leydig cell adenoma | <tumour> A small benign tumours of the testis that often produce testosterone, causing endocrine symptoms. Synonym: interstitial cell tumour of testis. (05 Mar 2000) |
| acetyl-CoA:alpha-glucosaminide acetyltransferase | <enzyme> An enzyme involved in the synthesis of certain carbohydrate moieties on proteins. A deficiency of this enzyme leads to mucopolysaccharidosis type III C. (05 Mar 2000) |
| adrenergic alpha-agonists | Drugs that selectively bind to and activate alpha adrenergic receptors. (12 Dec 1998) |
| adrenergic alpha-antagonists | Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (12 Dec 1998) |
| alpha | First letter of the Greek alphabet, a. (05 Mar 2000) |
| alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferase | <enzyme> Incorporates n-acetyglucosamine as the third branch of complex n-glycosyl-oligosaccharide of hen oviduct Registry number: EC 2.4.1.145 Synonym: glcnac-transferase iv, n-acetylglucosaminyltransferase iv, udp-glcnac-gngn(glcnac to man alpha1-3)beta 4-n-acetylglucosaminyltransferase iv (26 Jun 1999) |
| alpha-1,4-glucan lyase | <enzyme> Degrades alpha-1,4-glucan to produce 1,5-anhydrofructose; from seaweeds gracilariopsis lemaneiformis and gracilaria verrucosa; mw 111 kD; amino acid sequence has been determined Registry number: EC 4.2.2.- Synonym: alpha-1,4-glucan 4-lyase (26 Jun 1999) |
| alpha 1-4-mannosyltransferase | <enzyme> From mycobacterium smegmatis; involved in methylmannose polysaccharide elongation; GDP-mannose is donor Registry number: EC 2.4.1.- (26 Jun 1999) |
| alpha(1-6)mannosidase | <enzyme> Human lysosomal enzyme highly specific for alpha 1-6 mannose residues; inhibited by swainsonine; not the same enzyme which is deficient in alpha-mannosidosis Registry number: EC 3.2.1.- (26 Jun 1999) |
| alpha 1,6-mannosyltransferase | <enzyme> From saccharomyces cerevisiae; adds mannose residues in an alpha-1,6-linkage to man8glcnac and man9glcnac in the biosynthesis of the outer chain of yeast mannoproteins Registry number: EC 2.4.1.- (26 Jun 1999) |
| alpha-1 antichymotrypsin | <chemical> Glycoprotein found in alpha(1)-globulin region in human serum. It is an inhibiter of the digestive protease, chymotrypsin and other chymotrypsin-like proteinases in vivo and has cytotoxic killer-cell activity in vitro. The protein also has a role as an acute-phase protein and is active in the control of immunologic and inflammatory processes, and as a tumour marker. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. (12 Dec 1998) |